Home - Link
Pulmonary Hypertension - Scottish Pulmonary Vascular Unit - Health Care Professional Section

 

WHAT IS PH?

REFERRAL GUIDELINES

TREATMENT

CLINICAL TRIALS

DISCLAIMER

........................................

HOME : NEWS

WHAT IS PH? : EPIDEMIOLOGY

DEFINITION AND CLASSIFICATION / PATHOPHYSIOLOGY / EPIDEMIOLOGY / CLINICAL PRESENTATION / MANAGEMENT / NATURAL HISTORY


Epidemiology data on PAH have varied between publications and also depend on the aetiology of the condition. The most recent data have been published by the French National Reference Centre (1). The incidence in the French population was 2.4 per million per year and the prevalence was 15 per million which represent the lower limit of the true figures. The table below summarises the distribution of PAH cases according to aetiology in France.

 

Form of PAH % of PAH Cases Female : Male Mean Age at Diagnosis (yrs)
IPAH 40.5 1.6 : 1 52
FPAH 2.5 2.2 : 1 37
Connective tissue disease 18.2 3.9 : 1 56
Congenital heart disease 4.1 2.0 : 1 39
Portal hypertension 14.9 1: 1.5 52
Anorexigens 3.3 15 : 1 57
HIV 9.9 1 : 1.2 42

 

The proportion of patients with the condition affected by PAH varies widely and is summarized in the table below.

 

Condition % with PAH
Systemic sclerosis 12
Congenital heart disease 15-29
Portal hypertension 2
HIV 0.5

 

(1) Humbert M et al. Pulmonary arterial hypertension in France. Results from a national registry. AJRCCM 2006; 173: 1023-30.

 

Border
SCOTTISH PULMONARY VASCULAR UNIT - All rights reserved - Clydebank, Scotland - 0141 951 5497 - SPVUnit@gjnh.scot.nhs.uk